Home > Boards > Free Zone > User's Groups > Awesome Stocks

Even with the periodic gold sector smackdowns, Franco

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gfp927z Member Profile
 
Followed By 70
Posts 26,075
Boards Moderated 75
Alias Born 03/22/05
160x600 placeholder
Mastercard on Track for Lowest Close in Over a Year -- Data Talk
Mastercard Incorporated Class A (MA) is currently at $313.17, down $9.84 or 3.05%
Shell's Deer Park Texas Refinery Sale Delayed, Reuters Reports
Activision on Track for Longest Losing Streak Since January 2014 -- Data Talk
Cumberland Pharmaceuticals Shares Double, Hit 52-Week High
STOXX Europe 600 Index Ends the Month 2.64% Lower at 462.96 -- Data Talk
FTSE 100 Index Ends the Month 2.46% Lower at 7059.45 -- Data Talk
DAX Ends the Month 3.75% Lower at 15100.13 -- Data Talk
CAC 40 Index Ends the Month 1.60% Lower at 6721.16 -- Data Talk
STOXX Europe 50 Index Ends the Month 2.57% Lower at 3593.42 -- Data Talk
EURO STOXX 50 Index Ends the Month 4.41% Lower at 4063.06 -- Data Talk
U.S. Crude-Oil Stockpiles Likely Decreased in DOE Data, Analysts Say
FTSE Closes Down as Omicron Variant Sparks Volatility
Cabot Properties Sells Logistics Portfolio to Blackstone for $2.8 Billion
Oersted Secures 12-Year Power Purchase Contract With Google
Array Technologies Shares Fall With Plans for Convertible Notes Offering
Top Company News of the Day
U.S. Ethanol Production and Stocks Estimates for Nov. 26
TG Therapeutics Shares Drop 38% After Plans for Advisory Meeting
Consumer Confidence Fell in November Amid Inflation Worries
Clarus Therapeutics Shares Rise 27% on New U.S. Patents
Unemployment Rate Seen Ticking Down Again -- Data Week Ahead
MEI Pharma Shares Rise 22% After Positive Data for Zandelisib Trial
TG Therapeutics Shares Drop 35% Premarket After FDA Plans for Advisory Meeting
Codiak BioSciences Gets FDA Approval for ExoASO-STAT6 IND Application
MTN Group to Cut Stake in MTN Nigeria Via Share Placing
AbbVie Submits Europe Application for Risankizumab for Crohn's Disease
Hepion Pharmaceuticals Gets Fast-Track Designation for NASH Treatment
NextEra to Sell 50% Stake in Renewables Portfolio to Ontario Teachers' Pension Plan
Right Time for New Leadership, Inditex Chairman Says, as Founder's Daughter Prepares to Take His Place -- Update
Stellantis, Daimler's Mercedes-Benz Invest in Battery Maker Factorial Energy
gfp927z   Monday, 08/16/21 07:46:56 PM
Re: bigworld post# 50
Post # of 266 
Even with the periodic gold sector smackdowns, Franco Nevada is not far from its all time highs -


>>> The safest gold stock with a twist


https://www.fool.com/investing/2021/08/04/3-cheap-gold-stocks-to-buy-right-now/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article


One gold stock that's most unlikely to disappoint you regardless of what gold prices do is Franco-Nevada (NYSE:FNV). Its shares have historically outperformed those of the largest gold miners and are almost always the first to bounce back after a gold-price crash. There's a solid reasoning behind this pattern: Franco-Nevada earns a significantly higher margin, as it's a gold streaming company and so buys gold from mining companies for low prices to sell at spot rates without bearing any mining-related costs and risks.

With streams on more than 50 producing and 42 developing mines, Franco-Nevada can grow its sales as these mines expand, without having to spend money. Its largest revenue-generating gold stream mines include:

First Quantum's Cobre Panama in Panama.
Lundin Mining's Candelaria in Chile.
Glencore's Antapaccay in Peru.

Its low-cost, asset-light business model with leverage to gold prices also explains why Franco-Nevada has increased its dividend for 14 straight years now.

There's another reason to consider Franco-Nevada: the additional revenue sources it's exploring while remaining primarily a gold company. So after venturing into oil and gas some years ago, Franco-Nevada bought iron ore royalties from U.S. mining giant Vale and Canada-based Labrador Iron Ore this past April. Any rally in oil prices and uptick in infrastructure spending, and therefore demand for iron ore from steel manufacturers, should add to Franco-Nevada's top line.

With those additions, here's what Franco-Nevada's growth forecast now looks like:

Metric Actual 2020 2021 Guidance 2025 Guidance

Gold equivalent ounces (GEOs) sold 522,000 580,000-615,000 630,000-660,000
GEO revenue $928 million $1.05 billion $1.13 billion
Energy revenue $92 million $125 million $160 million
Total revenue $1.02 billion $1.18 billion $1.29 billion

DATA SOURCE: FRANCO-NEVADA.

Clearly, Franco-Nevada is headed for much bigger things after a record 2020. Chances are, if you check back in a couple of years, you'll think the stock was a steal at today's price.

<<<






Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences